BAP1-TPDS is characterized by increased risk of solid tumors, including mesothelioma, cutaneous and uveal melanoma, renal cell carcinoma, and BAP1-inactivated melanocytic tumors [2]. Here, BAP1 is linked to hereditary clear cell renal cell carcinoma.